Skip to main content
SpringerLink
Log in
Book cover

Multimodal Concepts for Integration of Cytotoxic Drugs pp 285–302Cite as

Concomitant Radiation and Chemotherapy in Muscle-Invasive Bladder Cancer

  • Chapter

  • 563 Accesses

Part of the Medical Radiology book series (Med Radiol Radiat Oncol)

Keywords

  • Bladder Cancer
  • Clin Oncol
  • Radiat Oncol Biol Phys
  • Radical Cystectomy
  • Radiation Therapy Oncology Group

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Advanced Bladder Cancer (ABC) (2005a) Meta-analysis collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 48:189–201

    CrossRef  Google Scholar 

  • Advanced Bladder Cancer (ABC) (2005b) Meta-analysis collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur Urol 48:202–206

    CrossRef  Google Scholar 

  • Arias F, Dominguez MA, Martinez E et al. (2000) Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 47:373–378

    CrossRef  PubMed  CAS  Google Scholar 

  • Bassi P, Ferrante GD, Piazza N et al. (1999) Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 161:1494–1497

    CrossRef  PubMed  CAS  Google Scholar 

  • Bellmunt J, Hussain M, Dinney CP (2003) Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family. Crit Rev Oncol Hematol 46(Suppl): S85–S104

    PubMed  Google Scholar 

  • Bredael JJ, Croker BP, Glenn JF (1980) The curability if invasive bladder cancer treated by radical cystectomy. Eur Urol 6:206–210

    PubMed  CAS  Google Scholar 

  • Caffo O, Fellin G, Graffer U et al. (2003) Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer. Int J Radiat Oncol Biol Phys 57:1310–1316

    CrossRef  PubMed  CAS  Google Scholar 

  • Cervak J, Cufer T, Marolt F et al. (1991) Combined chemotherapy and radiotherapy in muscle-invasive bladder carcinoma. Complete remission results. ECCO Proc 6:abstract 561

    Google Scholar 

  • Chakravati A, Winter K, Wu CL et al. (2005) Expression of the epidermal growth factor receptor and Her-2 are predictors of favourable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatinbased chemotherapy: a report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62:309–317

    CrossRef  CAS  Google Scholar 

  • Chen WC, Liaw CC, Chuang CK et al. (2003) Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 56:726–733

    CrossRef  PubMed  CAS  Google Scholar 

  • Cohen-Jonathan E, Muschel RJ, Gillies McKenna W et al. (2000) Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS. Radiat Res 154:125–132

    CrossRef  PubMed  CAS  Google Scholar 

  • Coppin CM, Gospodarowicz MK, James K et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14:2901–2907

    PubMed  CAS  Google Scholar 

  • Danesi DT, Arcangeli G, Cruciani E et al. (2004) Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long-term results. Cancer 101:2540–2548

    CrossRef  PubMed  Google Scholar 

  • Dreicer R, Gustin DM, See WA, Williams RD (1996) Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy. J Urol 156:1606–1608

    CrossRef  PubMed  CAS  Google Scholar 

  • Dunst J, Sauer R, Schrott KM et al. (1994) Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys 30:261–266

    PubMed  CAS  Google Scholar 

  • Dunst J, Rödel C, Zietman A et al. (2001) Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol 20:24–32

    CrossRef  PubMed  CAS  Google Scholar 

  • Dunst J, Rödel C (2003) Harnblase. In: Radioonkologie 2: Klinik. Hrsg: Bamberg M, Molls M, Sack H. Zuckschwerdt Verlag München. 672–691

    Google Scholar 

  • Eapen L, Stewart D, Danjoux C et al. (1989) Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J Clin Oncol 7:230–235

    PubMed  CAS  Google Scholar 

  • Eapen L, Stewart D, Collins J, Peterson R (2004) Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. J Urol 172:1276–1280

    CrossRef  PubMed  CAS  Google Scholar 

  • Fellin G, Graffer U, Bolner A et al. (1997) Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study. Br J Urol 80:44–49

    PubMed  CAS  Google Scholar 

  • Fossa SD, Waehre H, Aass N et al. (1993) Bladder cancer definitive radiation therapy of muscle invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72:3036–3043

    CrossRef  PubMed  CAS  Google Scholar 

  • Frazier HA, Robertson JE, Dodge RK, Paulson DF (1993) The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71:3993–4001

    CrossRef  PubMed  CAS  Google Scholar 

  • Ghersi D, Stewart LA, Parmar MKB et al. (1995) Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a metaanalysis of individual patient data from randomized clinical trials. Br J Urol:75–106

    Google Scholar 

  • Giuliani L, Giberti C, Martorana G et al. (1985) Results of radical cystectomy for primary bladder cancer. Retrospective study of more than 200 cases. Urology 26:243–248

    CrossRef  PubMed  CAS  Google Scholar 

  • Given RW, Parsons JT, McCarley D et al. (1995) Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up. Urology 46:499–504

    CrossRef  PubMed  CAS  Google Scholar 

  • Gospodarowicz M (2002) Radiotherapy and organ preservation in bladder cancer: Are we ignoring the evidence? J Clin Oncol 20:3048–3050

    PubMed  Google Scholar 

  • Gschwend JE, Fair WR, Vieweg J (2000) Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies. Eur Urol 38:121–130

    CrossRef  PubMed  CAS  Google Scholar 

  • Gupta AK, Cerniglia GJ, Ahmed MS et al. (2003) Radiation sensitisation of human cancer cells by inhibiting the acticity of PI3K using LY294002. Int J Radiat Oncol Biol Phys 56:846–853

    CrossRef  PubMed  CAS  Google Scholar 

  • Hagan MP, Winter KA, Kaufman DS et al. (2003) RTOG 97-06: initial report of a phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57:665–672

    CrossRef  PubMed  Google Scholar 

  • Hautmann RE (1998) Complications and results after cystectomy in male and female patients with locally invasive bladder cancer. Eur Urol 33(Suppl 4):23–24

    CrossRef  PubMed  Google Scholar 

  • Herr HW (1987) Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 138:1162–1163

    PubMed  CAS  Google Scholar 

  • Housset M, Maulard C, Chretien YC et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11:2150–2157

    PubMed  CAS  Google Scholar 

  • Housset M, Dufour E, Maulard-Durtux C et al. (1997) Concomitant 5-fluouracil-cisplatin and bifractionated split course radiation therapy for invasive bladder cancer. Proc Am Soc Clin Oncol 16:319, abstract 1139

    Google Scholar 

  • Hussain SA, Stocken DD, Peake DR et al. (2004) Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. Br J Cancer 90:2106–2111

    PubMed  CAS  Google Scholar 

  • Kachnic LA, Kaufmann DS, Griffin PP et al. (1997) Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15:1022–1029

    PubMed  CAS  Google Scholar 

  • Kaufman DS, Winter KA, Shipley WU (2000) The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5:471–476

    CrossRef  PubMed  CAS  Google Scholar 

  • Kent E, Sandler H, Montie J et al. (2004) Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol 22:2540–2545

    CrossRef  PubMed  CAS  Google Scholar 

  • Kragelj B, Zaletel-Kragelj L, Sedmark B, Cufer T, Cervek J (2005) Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer. Radiother Oncol 75:44–47

    CrossRef  PubMed  CAS  Google Scholar 

  • Maciejewski B, Majewski S (1991) Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 21:163–170

    CrossRef  PubMed  CAS  Google Scholar 

  • Maddineni SB, Sangar VK, Hendry JH et al. (2005) Differential radiosensitization by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines. Br J Cancer 92:125–130

    CrossRef  PubMed  CAS  Google Scholar 

  • Malkowicz SB, Nichols P, Lieskovsky G et al. (1990) The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144:641–645

    PubMed  CAS  Google Scholar 

  • Moore MJ, O’Sullivan B, Tannock I (1988) How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6:1736–1745

    PubMed  CAS  Google Scholar 

  • Nichols RC, Sweetser MG, Mahmood SK et al. (2000) Radiation therapy and concomitant paclitaxel/carboplatin for muscle-invasive transitional cell carcinoma of the bladder: a well-tolerated combination. Int J Cancer 90:281–286

    CrossRef  PubMed  CAS  Google Scholar 

  • Nieuwenhuijzen JA, Horenblas S, Meinhardt W et al. (2004) Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BMJ Int 94:793–797

    Google Scholar 

  • Pagano F, Bassi P, Galetti TP et al. (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145:45–50

    PubMed  CAS  Google Scholar 

  • Patel B, Forman J, Fontana J et al. (2005) A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. Int J Radiat Oncol Biol Phys 62:1332–1338

    CrossRef  PubMed  CAS  Google Scholar 

  • Peyromaure M, Slama J, Beuzeboc P et al. (2004) Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution. Urology 63:73–77

    CrossRef  PubMed  Google Scholar 

  • Rödel C (2004) Current status of radiation therapy and combined-modality treatment for bladder cancer. Strahlenther Onkol 180:701–709

    CrossRef  PubMed  Google Scholar 

  • Rödel C, Grabenbauer GG, Kuehn R et al. (2002a) Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Int J Radiat Oncol Biol Phys 52:1303–1309

    CrossRef  PubMed  Google Scholar 

  • Rödel C, Grabenbauer GG, Kuehn R et al. (2002b) Combined modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071

    CrossRef  PubMed  Google Scholar 

  • Rotman M, Aziz H, Porrazzo M et al. (1990) Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. Int J Radiat Oncol Biol Phys 18:1131–1137

    PubMed  CAS  Google Scholar 

  • Russell KJ, Boileau MA, Higano C et al. (1990) Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 19:693–699

    PubMed  CAS  Google Scholar 

  • Sangar VK, McBain CA, Lyons J et al. (2005) Phase I study of conformal radiotherapy with concurrent gemncitabine in locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 61:420–425

    CrossRef  PubMed  CAS  Google Scholar 

  • Sauer R, Birkenhake S, Kuehn R et al. (1998) Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40:121–127

    CrossRef  PubMed  CAS  Google Scholar 

  • Shelley MD, Wilt TJ, Barber J, Mason MD (2004) A meta-analysis of randomised trials suggest a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: Are these data relevant to modern practice? Clin Oncol 16:166–171

    CrossRef  CAS  Google Scholar 

  • Shipley WU, Prot GR, Kaufman SD, Perrone TL (1987) Invasive bladder carcinoma. The importance of intial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60(Suppl) 3:514–520

    CrossRef  PubMed  CAS  Google Scholar 

  • Shipley WU, Winter KA, Kaufman DS (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16:3576–3583

    PubMed  CAS  Google Scholar 

  • Shipley WU, Zietman AL, Kaufman DS et al. (2005) Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates: the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 15:36–41

    CrossRef  PubMed  Google Scholar 

  • Skinner DG, Lieskovsky G (1988) 16 years experience in the management of patients with deeply invasive bladder cancer. Eur Urol 14(Suppl 1):30–31

    PubMed  Google Scholar 

  • Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34–36

    PubMed  CAS  Google Scholar 

  • Smith JA Jr, Whitmore WF Jr (1981) Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol 125:643–645

    PubMed  Google Scholar 

  • Stein JP, Lieskovsky G, Cote R et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19:666–675

    PubMed  CAS  Google Scholar 

  • Swanson DA, Eschenbach AC von, Bracken RB, Johnson DE (1981) Salvage cystectomy for bladder carcinoma. Cancer 47:2275–2279

    CrossRef  PubMed  CAS  Google Scholar 

  • Tester W, Porter A, Asbell S et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25:783–790

    PubMed  CAS  Google Scholar 

  • Tester W, Porter A, Heaney J et al. (1996) Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer. J Clin Oncol 14:119–126

    PubMed  CAS  Google Scholar 

  • Timmer PR, Hartlief HA, Hooijkaas JA (1985) Bladder cancer: pattern of recurrence in 142 patients. Int J Radiat Oncol Biol Phys 11:899–905

    PubMed  CAS  Google Scholar 

  • Vaughn DJ, Manola J, Dreicer R et al. (2002) Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): a trial of the Eastern Cooperative Oncology Group. Cancer 95:1022–1027

    CrossRef  PubMed  CAS  Google Scholar 

  • Vaveris H, Delakas D, Anezinis P et al. (1997) Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control. Anticancer Res 17:4771–4780

    Google Scholar 

  • Vieweg J, Gschwend JE, Herr HW, Fair WR (1999) The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161:72–76

    CrossRef  PubMed  CAS  Google Scholar 

  • Waehre H, Ous S, Klevmark B et al. (1993) A bladder cancer multi-institutional experience with total cystectomy for muscle invasive bladder cancer. Cancer 72:3044–3051

    CrossRef  PubMed  CAS  Google Scholar 

  • Wallace DM, Bloom HJ (1976) The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy. Br J Urol 48:587–594

    CrossRef  PubMed  CAS  Google Scholar 

  • Weiss C, Roedel F, Wolf I et al. (2005) Combined-modality treatment and organ-preservation in bladder cancer. Do molecular markers predict outcome? Strahlenther Onkol 181:213–222

    CrossRef  PubMed  Google Scholar 

  • Wishnow KI, Tenney DM (1991) Will Rogers and the results of radical cystectomy for invasive bladder cancer. Urol Clin North Am 18:529–537

    PubMed  CAS  Google Scholar 

  • Yu WS, Sagerman RH, Chung CT et al. (1985) Bladder carcinoma: experience with radical and preoperative radiotherapy in 421 patients. Cancer 56:1293–1299

    CrossRef  PubMed  CAS  Google Scholar 

  • Zapatero A, Martin de Vidales C, Marin A et al. (2000) Invasive bladder cancer: a single-institution experience with bladder-sparing approach. Int J Cancer 90:287–294

    CrossRef  PubMed  CAS  Google Scholar 

  • Zietman A, Skinner E (2005) Quality of life after radical treatment for invasive bladder cancer. Semin Radiat Oncol 15:55–59

    CrossRef  PubMed  Google Scholar 

  • Zietman AL, Shipley WU, Kaufman DS (1993) The combination of cis-platinum based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 27:161–170

    PubMed  CAS  Google Scholar 

  • Zietman AL, Kaufman DS, Shipley WU et al. (1997) Phase I/II trial of transurethral surgery plus cisplatin and radiation therapy followed either by selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis. Int J Radiat Oncol Biol Phys (Suppl 2):abstract 42

    Google Scholar 

  • Zincke H, Patterson DE, Utz DC, Benson RC Jr (1985) Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease. Br J Urol 57:156–159

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany

    Jürgen Dunst MD (Professor)

  2. Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen, Universitätsstrasse 27, 91054, Erlangen, Germany

    Claus Rödel MD

  3. Department of Radiation Oncology, Massachusetts General Hospital, 101 Blossom Street, Boston, MA, 02114, USA

    Anthony Zietman MD

Authors
  1. Jürgen Dunst MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claus Rödel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anthony Zietman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dunst, J., Rödel, C., Zietman, A. (2006). Concomitant Radiation and Chemotherapy in Muscle-Invasive Bladder Cancer. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_19

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation